Page last updated: 2024-10-31

minoxidil and Dizziness

minoxidil has been researched along with Dizziness in 2 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Dizziness: An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.

Research Excerpts

ExcerptRelevanceReference
"The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects."1.62Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. ( Bhoyrul, B; Hermosa-Gelbard, A; Jaén-Olasolo, P; Jerjen, R; Jimenez-Cauhe, J; John, JM; Koh, WL; Lo-Sicco, K; Moreno-Arrones, ÓM; Piraccini, BM; Pirmez, R; Poa, JE; Rodrigues-Barata, R; Rudnicka, L; Saceda-Corralo, D; Salas-Callo, CI; Shapiro, J; Sinclair, R; Starace, M; Tosti, A; Trindade de Carvalho, L; Vañó-Galván, S; Vincenzi, C; Waskiel-Burnat, A; Yin, L; Zamorano, JL, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Vañó-Galván, S1
Pirmez, R1
Hermosa-Gelbard, A1
Moreno-Arrones, ÓM1
Saceda-Corralo, D1
Rodrigues-Barata, R1
Jimenez-Cauhe, J1
Koh, WL1
Poa, JE1
Jerjen, R1
Trindade de Carvalho, L1
John, JM1
Salas-Callo, CI1
Vincenzi, C1
Yin, L1
Lo-Sicco, K1
Waskiel-Burnat, A1
Starace, M1
Zamorano, JL1
Jaén-Olasolo, P1
Piraccini, BM1
Rudnicka, L1
Shapiro, J1
Tosti, A1
Sinclair, R1
Bhoyrul, B1
Molitor, L1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomised, Crossover Bioavailability Clinical Trial of Oral Minoxidil 1 MG, After Single and Multiple Dose Administration to Healthy Volunteers Under Fasting Conditions.[NCT06015516]Phase 114 participants (Anticipated)Interventional2024-02-29Not yet recruiting
International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia[NCT05888922]Phase 3520 participants (Anticipated)Interventional2024-03-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for minoxidil and Dizziness

ArticleYear
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema;

2021
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema;

2021
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema;

2021
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema;

2021
A 45-year-old man with dizziness.
    Journal of emergency nursing, 1999, Volume: 25, Issue:1

    Topics: Alopecia; Dizziness; Emergency Nursing; Humans; Male; Middle Aged; Minoxidil; Nursing Assessment; Tr

1999